FIRMAGON 120 MG 2 SUBCUTANEOUS VIALS

Degarelix is a hormonal therapy used in the treatment of prostate cancer. Degarelix has an immediate onset of action binding to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and blocking their interaction with GnRH. This induces a fast and profound reduction in luteinising hormone (LH) follicle-stimulating hormone (FSH) and in turn testosterone suppression.